Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ADAM33
REST API REST API
Homo sapiens
ADAM33 is differentially expressed in 140 experiments: 89 organism parts: bone marrow, cerebellum, ... (87 more);, 57 disease states: normal, Huntington's disease, ... (55 more);, 46 cell types 162 cell lines 9 compound treatments and 51 other conditions.
Synonyms dJ964F7.1, C20orf153, DKFZp434K0521
Orthologs Adam33 (Mus musculus)   ADAM33 (Bos taurus)   ADAM33 (Gallus gallus)   ADAM33 (Danio rerio)   D4ADH4_RAT (Rattus norvegicus)   adam33 (Xenopus laevis)   ADAM33 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, metalloendopeptidase activity, membrane, peptidase activity, metal ion binding, integrin-mediated signaling pathway, proteolysis, integral to membrane, zinc ion binding
InterPro Term Peptidase_M12B_N, Blood-coag_inhib_Disintegrin, ADAM_Cys-rich, EGF_3, Peptidase_M12B
UniProt Accession Q8N6B9, Q08AM2, Q08AM3, Q6P5U4, Q7Z7E3, Q7Z7E1, Q8N8Z9, Q9BZ11, A2A2L3, F5H888, E7ET13, E9PEB2, Q7Z7E4
Gene-Disease Assocation ASTHMA, SUSCEPTIBILITY TO
Search EB-eye ENSG00000149451
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-22541, E-GEOD-6573, E-GEOD-18105, ... (12 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, E-MEXP-980, ... (16 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-5823, E-GEOD-19639, E-GEOD-20081
U87
2
E-MEXP-903, E-GEOD-20089
KU812
1
E-MTAB-37
PC3
1
E-MEXP-2034
SKMEL1
1
E-MTAB-37
NCIH1437
1
E-MTAB-37
156 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-22373, E-GEOD-21668, E-GEOD-20033, ... (24 experiments)

Factor Value U/D Experiments
stromal cell
1
2
E-MEXP-2034, E-GEOD-1460, E-GEOD-3998
testis - germ cell
1
E-AFMX-5
squamous cell carcinoma
1
E-GEOD-17347
immortalised T lymphocytes
1
E-GEOD-13909
induced pluripotent stem cell
1
E-GEOD-18265
fetal RPE
1
E-GEOD-18811
40 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-MEXP-1121, E-TABM-26, E-GEOD-22148, ... (32 experiments)

Factor Value U/D Experiments
prostate carcinoma
2
E-TABM-26, E-MEXP-2034
Huntington's disease
1
2
E-AFMX-6, E-GEOD-3790
Nodular Goiter
1
1
E-MEXP-2442
no inhalation injury
1
E-GEOD-19743
acute HIV-1 infection
1
E-GEOD-16363
anaplastic large cell lymphoma
1
E-GEOD-6338
51 more value(s).


Compound treatment

studied in E-MEXP-1601, E-GEOD-3284, E-GEOD-6400, E-MEXP-2590, E-GEOD-20081 ... (5 experiments)

Factor Value U/D Experiments
control
10
1
E-GEOD-3284
NaOH
1
1
E-MEXP-2590
none
1
E-MEXP-1601
no estradiol
1
E-GEOD-20081
estradiol
1
1
E-GEOD-20081
bacterial endotoxin
1
1
E-GEOD-3284
3 more value(s).


Age at diagnosis

studied in E-GEOD-21653

Factor Value U/D Experiments
31
1
E-GEOD-21653


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-TABM-302, E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21374, ... (9 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-3325, E-GEOD-22541, E-GEOD-22148, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-20847, E-GEOD-2299

Genotype
studied in E-GEOD-22056, E-GEOD-3494, E-GEOD-17476, E-TABM-868, E-TABM-601, ... (8 experiments)

Gestation age
studied in E-GEOD-14334

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-GEOD-9764, E-GEOD-10315, E-MEXP-1103 ... (5 experiments)

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1956, E-MEXP-2069, E-TABM-666, ... (18 experiments)

Infection
studied in E-GEOD-12108

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-19703

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Sample preparation
studied in E-GEOD-16728

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-3860, E-GEOD-7307

Stimulation
studied in E-GEOD-20114

stimulus
studied in E-GEOD-22103

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-3494, E-GEOD-22541, E-GEOD-4922 ... (5 experiments)

Processing time: 0.408 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM